Piramal Enterprises up 1%, acquires drugs portfolio of Mallinckrodt
Most Popular (6 hours)

Lok Sabha passes four GST Bills

- news.statetimes.in

The Strategist Quiz (#504)

- business-standard

Why this cover up?

- news.statetimes.in

Govt bans inter-cadre transfers

- news.statetimes.in

Most Popular (24 hours)

Most Popular (a week)

moneycontrol.com
10 days ago

Piramal Enterprises up 1%, acquires drugs portfolio of Mallinckrodt

The portfolio acquired includes Gablofen (baclofen), a severe spasticity management product, which is currently marketed in the United States, and two pain management products, which are currently under development.

Read on the original site


Haley defends Trump travel ban

- business-standard

Digital is changing the way we work

- financialexpress.com

Delhi confidential

- indianexpress.com

Shutdown paralyses dozens injured

- dailyexcelsior.com

Dr Dogra gets B C Roy Award

- dailyexcelsior.com

Shiv Khori Shrine

- news.statetimes.in

Towards a horticulture revolution

- news.statetimes.in

Cold concrete

- news.statetimes.in

Right to Disagree

- news.statetimes.in

Lok Sabha passes four GST Bills

- news.statetimes.in

Govt bans inter-cadre transfers

- news.statetimes.in

Why this cover up?

- news.statetimes.in

Rashid detained in Srinagar

- news.statetimes.in

Dozens rescued off Cyprus coast

- business-standard
Hashtags:   

Piramal

 | 

Enterprises

 | 

acquires

 | 

drugs

 | 

portfolio

 | 

Mallinckrodt

 |